M. Brownlee
Impact in
- Clinical Biochemistry top 0.02%
- Advanced Glycation End Products research
-
- Natural Antidiabetic Agents Studies
- Diabetes, Cardiovascular Risks, and Lipoproteins
Papers in
-
- Advanced Glycation End Products research 23
-
- Natural Antidiabetic Agents Studies 7
- Co-authors
- Anthony Cerami (13 shared papers)Helen Vlassara (11 shared papers)Diane Edelstein (9 shared papers)Peter C. Ulrich (1 shared paper)Ida Giardino (3 shared papers)Qida Ju (2 shared papers)K. Federlin (4 shared papers)Stefanie Dimmeler (1 shared paper)
- Journals
- Diabetologia (17 papers)Diabetes (10 papers)Proceedings of the National Academy of Sciences (4 papers)Journal of Clinical Investigation (3 papers)The Journal of Experimental Medicine (2 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
M. Brownlee
51 papers receiving 6.2k citations
M. Brownlee's Hit Papers
Peers
Comparison fields: 5 of 123
- Clinical Biochemistry 3.0k
- Endocrinology, Diabetes and Metabolism 1.9k
- Ophthalmology 620
- Neurology 466
- Nephrology 390
Countries citing papers authored by M. Brownlee
This map shows the geographic impact of M. Brownlee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Brownlee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Brownlee more than expected).
Fields of papers citing papers by M. Brownlee
This network shows the impact of papers produced by M. Brownlee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Brownlee. The network helps show where M. Brownlee may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Brownlee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking Hit paper breakdown → | 1986 | 1040 |
| 2 | 2001 | 762 | |
| 3 | 1991 | 473 | |
| 4 | 1981 | 361 | |
| 5 | 1985 | 278 | |
| 6 | 1998 | 236 | |
| 7 | 1996 | 224 | |
| 8 | 1998 | 204 | |
| 9 | 2004 | 185 | |
| 10 | 1999 | 175 | |
| 11 | 1999 | 174 | |
| 12 | 1992 | 165 | |
| 13 | 2003 | 157 | |
| 14 | 2010 | 147 | |
| 15 | The pathological implications of protein glycation. | 1995 | 142 |
| 16 | 1986 | 140 | |
| 17 | 2011 | 136 | |
| 18 | Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications. | 1986 | 120 |
| 19 | 1994 | 108 | |
| 20 | 1992 | 96 |
About M. Brownlee
M. Brownlee is a scholar working on Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Neurology, Ophthalmology and Genetics, having authored 51 papers that have together received 6.7k indexed citations. Recurring topics across this work include Advanced Glycation End Products research (23 papers), Diabetes and associated disorders (7 papers), Pancreatic function and diabetes (7 papers), Natural Antidiabetic Agents Studies (7 papers), Glycosylation and Glycoproteins Research (6 papers), Retinal Diseases and Treatments (6 papers), Neurological Disorders and Treatments (5 papers) and Retinal Imaging and Analysis (3 papers). The work is most often cited by research in Clinical Biochemistry (3.0k citations), Endocrinology, Diabetes and Metabolism (1.9k citations), Ophthalmology (620 citations), Neurology (466 citations) and Nephrology (390 citations). M. Brownlee has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Anthony Cerami, Helen Vlassara, Diane Edelstein, Peter C. Ulrich, Ida Giardino, Qida Ju, K. Federlin, Stefanie Dimmeler, Hans‐Peter Hammes and S. Martin. Their work appears in journals such as Diabetologia, Diabetes, Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.